How is your business helping to solve the health, social, or economic challenges created by COVID19?
Children with chronic diseases are having a particularly difficult time during the current crisis, with heightened fears of infection, reduced contact with support workers and harder to access healthcare services. For those that are immuno-compromised the situation is especially difficult. With the need for self-isolation and health services pushed to breaking point, it is vitally important that mechanisms are developed to enhance remote patient reporting, minimising face-to-face interactions. That's why we are developing our 'PROMs module' – allowing clinicians to monitor patients remotely.
Does your business contribute most to recovery, response, or resilience?
Response - we're responding directly to issues caused or exacerbated by the COVID-19 outbreak.
What is the stage of your product development?
I have a market ready product/service. I have sold to customers.
What strengths does your team bring? Include skills and personal experience with the problem.
Xploro is a result of the personal experience of co-founder, Dom Raban. In 2011 his daughter, who was 13 at the time, was diagnosed with cancer. She's now fit and well but it was this experience that led him to develop Xploro. A designer by background, Dom has over 30 years experience managing Digital and Creative Agencies and for the last 10 years he has specialised in mobile applications and emerging technologies. His co-founder, Dan Taylor, has been in business with Dom for the last 13 years and together they've grown a very successful mobile digital agency.Dom and Dan are joined by Oisin Wood who is CTO. Oisin was hired by Dom and Dan in 2012 for the agency they ran at the time, initially as a Junior Developer but quickly growing to become Tech Lead within 4 years. Mike Tebbutt is part-time CTO. He has held C-level positions at healthcare (Boots), gaming (Codemasters) and SaaS businesses.The board includes Dr Peter-Marc Fortune, Clinical Director at the biggest children's hospital in the UK and is chaired by Kevin McDonnell who has 20 years’ international leadership and board experience building, scaling and growing healthcare, technology, digital and data companies, ranging from 50 to 2,500 people and revenues between £3m - £160m. Previous roles include Managing Director at AIM listed EMIS Group where he led the EMIS Care and EMIS Health Specialist businesses.
What countries do you operate in?
We are based in the UK. We currently have trials underway in Spain, Singapore and Australia and have strong links with The national Cancer Institute in Maryland and Children's National in Washington DC.
Is your company headquartered in a US "Opportunity Zone"?
Yes
